Challenges with sensitized recipients in pediatric heart transplantation.

Common challenge topics in pediatric transplantation. Clinics (Sao Paulo) (2014) 0.75

Significance of the positive crossmatch test in kidney transplantation. N Engl J Med (1969) 5.50

Anti-inflammatory actions of intravenous immunoglobulin. Annu Rev Immunol (2008) 3.05

Allosensitization and outcomes in pediatric heart transplantation. J Heart Lung Transplant (2011) 1.78

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol (2004) 1.68

Anti-HLA antibodies after solid organ transplantation. Transplantation (2000) 1.54

HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction. Am J Transplant (2005) 1.46

Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era. Ann Thorac Surg (2007) 1.39

Intravenous immunoglobulins--understanding properties and mechanisms. Clin Exp Immunol (2009) 1.34

Normal human kidney HLA-DR-expressing renal microvascular endothelial cells: characterization, isolation, and regulation of MHC class II expression. J Am Soc Nephrol (2003) 1.32

Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients. J Heart Lung Transplant (2010) 1.31

Survival in allosensitized children after listing for cardiac transplantation. J Heart Lung Transplant (2007) 1.30

HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection. J Heart Lung Transplant (2004) 1.27

HLA antibody analysis: sensitivity, specificity, and clinical significance in solid organ transplantation. Immunol Res (2006) 1.22

Sensitization and sensitivity: defining the unsensitized patient. Transplantation (2000) 1.21

Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy. J Heart Lung Transplant (2007) 1.18

Pediatric heart transplantation in human leukocyte antigen sensitized patients: evolving management and assessment of intermediate-term outcomes in a high-risk population. Circulation (2007) 1.13

Anti-HLA antibody analysis and crossmatching in heart and lung transplantation. Transpl Immunol (2004) 1.12

Evolution of HLA antibody detection: technology emulating biology. Immunol Res (2004) 1.05

Pediatric cardiac transplantation in children with high panel reactive antibody. Ann Thorac Surg (2004) 1.05

Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation. J Heart Lung Transplant (1992) 1.02

Anti-HLA alloantibodies in pediatric solid organ transplantation. Pediatr Transplant (2006) 1.00

C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody. Transpl Immunol (2005) 1.00

Pretransplant panel reactive-antibody screens. Are they truly a marker for poor outcome after cardiac transplantation? Circulation (1996) 0.97

The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation. Transpl Immunol (1993) 0.97

Immunological function of the endothelial cell within the setting of organ transplantation. Immunol Lett (2011) 0.94

Reduction of alloantibodies via proteasome inhibition in cardiac transplantation. J Heart Lung Transplant (2011) 0.90

HLA sensitization in pediatric pre-transplant cardiac patients supported by mechanical assist devices: the utility of Luminex. J Heart Lung Transplant (2009) 0.90

The Registry of the International Society for Heart and Lung Transplantation: fifteenth pediatric heart transplantation report--2012. J Heart Lung Transplant (2012) 0.89

Cardiac transplant outcomes in pediatric patients with pre-formed anti-human leukocyte antigen antibodies and/or positive retrospective crossmatch. J Heart Lung Transplant (2007) 0.89

Listing requirements for a prospective crossmatch in pediatric heart transplantation: analysis of Organ Procurement and Transplantation Network data from 1996 to 2009. J Heart Lung Transplant (2012) 0.88

Increased antibody responsiveness to blood transfusions in pediatric patients. Transplantation (1994) 0.88

The long-term outcome of treated sensitized patients who undergo heart transplantation. Clin Transplant (2010) 0.87

Mycophenolic mofetil reduces the HLA antibody response of children to valved allograft implantation. Ann Thorac Surg (2004) 0.86

The sensitized pediatric heart transplant candidate: causes, consequences, and treatment options. Pediatr Transplant (2005) 0.86

Impact of ELISA-detected anti-HLA antibodies on pediatric cardiac allograft outcome. Hum Immunol (2005) 0.84

Histocompatibility methods. Transplant Rev (Orlando) (2009) 0.84

Ventricular assist device-associated anti-human leukocyte antigen antibody sensitization in pediatric patients bridged to heart transplantation. J Heart Lung Transplant (2010) 0.83

Peritransplant immunoadsorption: a strategy enabling transplantation in highly sensitized crossmatch-positive cadaveric kidney allograft recipients. Transplantation (2005) 0.83

Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation. Am J Transplant (2010) 0.82

Immunoadsorption with protein A in humoral rejection of kidney transplants. ASAIO J (1997) 0.79

Utilization of intravenous immunoglobulin to ameliorate alloantibodies in a highly sensitized patient with a cardiac assist device awaiting heart transplantation. Fluorescence-activated cell sorter analysis. Transplantation (1996) 0.78

Outcomes of cardiac transplantation in highly sensitized pediatric patients. Pediatr Cardiol (2011) 0.78

Evaluation of anti-human leukocyte antigen allo-immunization in pediatric cadaveric kidney transplantation. Pediatr Transplant (2000) 0.77

Glutaraldehyde treatment of allograft tissue decreases allosensitization after the Norwood procedure. J Thorac Cardiovasc Surg (2010) 0.77

Renal retransplantation in children. J Pediatr (1979) 0.76

Association between the presence of anti-HLA antibodies with acute rejection and chronic allograft nephropathy in the first year after kidney transplantation. Transplant Proc (2008) 0.76

HLA desensitization in pediatric heart transplant candidates: efficacy of rituximab and IVIg. J Heart Lung Transplant (2012) 0.76

Predictive value of enzyme-linked immunosorbent assay-detected IgG anti-HLA antibodies for pediatric renal allograft rejection. Transplantation (1997) 0.76

Heart transplantation across the antibodies against HLA and ABO. Transpl Int (2006) 0.76

Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies. Xenotransplantation (2006) 0.76